SFAF.org Podcast #37 - Mitchell Warren on HIV vaccine research setbacks and evidence-based HIV prevention
In this episode, Mitchell Warren, Executive Director of the AIDS Vaccine Advocacy Coalition, discusses the recent cancellation of the next round of HIV vaccine trials by the NIH and the relationship between behavioral HIV interventions and continued vaccine research. Mitchell will be co-chairing a satellite session at the International AIDS Conference in Mexico City with the Foundation's Dr. Judith Auerbach entitled "Confronting the 'Evidence' in Evidence-based HIV Prevention." For the latest information on evidence-based HIV prevention, be sure to read the Foundation's new Summary Report and look for a recording of the Mexico City satellite session on the sfaf.org policy page in mid-August. We'll also have podcast interviews and updates from Mexico City on the podcast web site during the International AIDS Conference.
Get the Flash Player to listen to our podcast in your browser.
Mitchell Warren is the Executive Director of AVAC, an international non-governmental organization that uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of AIDS vaccines and other HIV prevention options. He previously served as Senior Director for Vaccine Preparedness at the International AIDS Vaccine Initiative (IAVI). Warren spent six years at Population Services International (PSI) designing and implementing social marketing, communications and health promotion activities, including five years running PSI's project in South Africa. He has a B.A. in English and History from the University of Wisconsin-Madison and studied health policy at the Johns Hopkins University School of Hygiene and Public Health.
To listen to our podcast on your computer or mp3 player, download this episode of the SFAF Podcast. If you need podcast help or would like to subscribe to the podcast through iTunes or another program, please visit our podcast help page.
Comments